141 related articles for article (PubMed ID: 9164601)
1. Fine epitope specificity of antibodies to region II of the Plasmodium vivax circumsporozoite protein correlates with ability to bind recombinant protein and sporozoites.
Bilsborough J; Baumgart K; Bathurst I; Barr P; Good MF
Acta Trop; 1997 May; 65(2):59-80. PubMed ID: 9164601
[TBL] [Abstract][Full Text] [Related]
2. Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.
Cabrera-Mora M; Fonseca JA; Singh B; Oliveira-Ferreira J; Lima-Junior Jda C; Calvo-Calle JM; Moreno A
Infect Immun; 2015 Sep; 83(9):3749-61. PubMed ID: 26169267
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
[TBL] [Abstract][Full Text] [Related]
4. Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.
Arévalo-Herrera M; Roggero MA; Gonzalez JM; Vergara J; Corradin G; López JA; Herrera S
Ann Trop Med Parasitol; 1998 Jul; 92(5):539-51. PubMed ID: 9797827
[TBL] [Abstract][Full Text] [Related]
5. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody.
Jones TR; Yuan LF; Marwoto HA; Gordon DM; Wirtz RA; Hoffman SL
Am J Trop Med Hyg; 1992 Dec; 47(6):837-43. PubMed ID: 1471743
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax.
Millet P; Chizzolini C; Wirtz RA; Bathurst I; Broderson JR; Campbell GH; Collins WE
Eur J Immunol; 1992 Feb; 22(2):519-24. PubMed ID: 1371470
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to the circumsporozoite protein of Plasmodium vivax in naturally infected humans.
Franke ED; Lucas CM; Chauca G; Wirtz RA; Hinostroza S
Am J Trop Med Hyg; 1992 Mar; 46(3):320-6. PubMed ID: 1373042
[TBL] [Abstract][Full Text] [Related]
8. Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection.
Shabani SH; Zakeri S; Salmanian AH; Amani J; Mehrizi AA; Snounou G; Nosten F; Andolina C; Mourtazavi Y; Djadid ND
Mol Immunol; 2017 Oct; 90():158-171. PubMed ID: 28800475
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.
de Camargo TM; de Freitas EO; Gimenez AM; Lima LC; de Almeida Caramico K; Françoso KS; Bruna-Romero O; Andolina C; Nosten F; Rénia L; Ertl HCJ; Nussenzweig RS; Nussenzweig V; Rodrigues MM; Reyes-Sandoval A; Soares IS
Sci Rep; 2018 Jan; 8(1):1118. PubMed ID: 29348479
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunological responses to the various types circumsporozoite proteins of Plasmodium vivax in malaria patients of Korea.
Suh IB; Lee KH; Kim YR; Woo SK; Kang HY; Won YD; An SS; Cho M; Cho D; Lim CS
Microbiol Immunol; 2004; 48(2):119-23. PubMed ID: 14978337
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune responses to the circumsporozoite protein of Plasmodium vivax in Madagascar.
Migot F; Millet P; Chougnet C; Lepers JP; Deloron P
Am J Trop Med Hyg; 1993 Apr; 48(4):524-9. PubMed ID: 7683178
[TBL] [Abstract][Full Text] [Related]
12. Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax.
Cochrane AH; Nardin EH; de Arruda M; Maracic M; Clavijo P; Collins WE; Nussenzweig RS
Am J Trop Med Hyg; 1990 Nov; 43(5):446-51. PubMed ID: 2122747
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.
Teixeira LH; Tararam CA; Lasaro MO; Camacho AG; Ersching J; Leal MT; Herrera S; Bruna-Romero O; Soares IS; Nussenzweig RS; Ertl HC; Nussenzweig V; Rodrigues MM
Infect Immun; 2014 Feb; 82(2):793-807. PubMed ID: 24478093
[TBL] [Abstract][Full Text] [Related]
14. Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax.
Romero P; Heimer EP; Herrera S; Felix AM; Nussenzweig RS; Zavala F
J Immunol; 1987 Sep; 139(5):1679-82. PubMed ID: 2442254
[TBL] [Abstract][Full Text] [Related]
15. Use of synthetic peptides in the study of the antibody response to Plasmodium vivax sporozoites.
Pessi A; Michel M; Bianchi E; Mendis A; Tougne C; Verdini AS; Lambert PH; Carter R; Mendis K; Del Giudice G
Am J Trop Med Hyg; 1990 Jan; 42(1):17-23. PubMed ID: 1689124
[TBL] [Abstract][Full Text] [Related]
16. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
[TBL] [Abstract][Full Text] [Related]
17. Antibodies Against the
França ACB; Françoso KS; Marques RF; Trossini GHG; Gomes RA; Póvoa MM; Cunha MG; Silveira ELV; Soares IS
Front Cell Infect Microbiol; 2021; 11():616230. PubMed ID: 33796476
[TBL] [Abstract][Full Text] [Related]
18. Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.
Cheng Y; Ito D; Sattabongkot J; Lim CS; Kong DH; Ha KS; Wang B; Tsuboi T; Han ET
Malar J; 2013 Sep; 12():323. PubMed ID: 24034268
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the humoral response to repeat and non-repeat sequences of the circumsporozoite protein of Plasmodium vivax using novel adjuvant and delivery systems.
Thomas BE; Manocha M; Haq W; Adak T; Pillai CR; Rao DN
Ann Trop Med Parasitol; 2001 Jul; 95(5):451-72. PubMed ID: 11487368
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
